Verkuijl S, Brands A, Viney K, Masini T, Mavhunga F, Kasaeva T. WHO operational handbook on tuberculosis: module 5: management of tuberculosis in children and adolescents. Geneva: World Health Organization. 2022;Licence: CC BY-NC-SA 3.0 IGO.

Tuberculosis [TB] [Internet]. [cited 2022 Jul 19]. Centers for Disease Control and Prevention. Available from: https://www.cdc.gov/tb/topic/basics/default.htm

Adams LV, Starke JR. UpToDate. 2022 [cited 2022 Jul 19]. Tuberculosis disease in children. Available from: https://www.uptodate.com/contents/tuberculosis-disease-in-children/print

Adeleke OA, Tsai PC, Karry KM, Monama NO, Michniak-Kohn BB. Isoniazid-loaded orodispersible strips: methodical design, optimization and in vitro-in silico characterization. Indian J Pharm. 2018;547:347–59.

CAS  Google Scholar 

Global Tuberculosis Report 2021. Geneva: World Health Organization Licence: CC BY-NC-SA 30 IGO. 2021 [Internet]. [cited 2022 Aug 9]. Available from: https://www.who.int/publications/i/item/9789240037021

World Health Organization [Internet]. [cited 2022 Nov 15]. Tuberculosis. Available from: https://www.who.int/news-room/fact-sheets/detail/tuberculosis

TB Alliance [Internet]. 2022 [cited 2022 Aug 10]. Child-friendly medicines. Available from: https://www.tballiance.org/child-friendly-medicines

Global Tuberculosis Report 2022. 2.2 TB mortality [Internet]. [cited 2023 Aug 8]. Available from: https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2022/tb-disease-burden/2-2-tb-mortality

Suárez-González J, Santoveña-Estévez A, Soriano M, Fariña JB. Design and optimization of a child-friendly dispersible tablet containing isoniazid, pyrazinamide, and rifampicin for treating tuberculosis in pediatrics. Drug Dev Ind Pharm. 2020;46(2):309–17.

Article  PubMed  Google Scholar 

Maphalle LN, Michniak-Kohn BB, Ogunrombi MO, Adeleke OA. Pediatric tuberculosis management: a global challenge or breakthrough. Children. 2022;9(8):1120.

Legese H, Degefa H, Gebrewahd A, Gebremedhin H. Utilization of isoniazid prophylaxis therapy and its associated factors among HIV positive clients taking antiretroviral therapy at Fre Semaetat primary hospital, Hawzien districts, Tigrai, Northern Ethiopia. Tropical Diseases, Travel Medicine and Vaccines. 2020;6(1):1–7.

Article  Google Scholar 

Lexicomp [Internet]. 2022 [cited 2022 Jul 19]. Isoniazid [Lexi-Drugs]. Available from: https://online-lexi-com.ezproxy.library.dal.ca/lco/action/home

National Center for Biotechnology Information [Internet]. 2004 [cited 2022 Jul 19]. PubChem compound summary for CID 3767, isoniazid. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/Isoniazid

Isoniazid 300 mg Tablets. WHOPAR part 6 [Internet]. 2018 [cited 2022 Aug 9]. Available from: https://extranet.who.int/pqweb/sites/default/files/TB285part6.pdf

Government of Canada [Internet]. 2015 [cited 2022 Jun 15]. Drug Product Database: access the database. Available from: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html

U.S. Food & Drug Administration [Internet]. [cited 2022 Aug 9]. Food and Drug Administration-approved drugs. Available from: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm

Adeleke OA, Hayeshi RK, Davids H. Development and evaluation of a reconstitutable dry suspension containing isoniazid for flexible pediatric dosing. Pharmaceutics. 2020;12(3):286.

Neves I, Auxtero MD. Dosing accuracy of oral extemporaneous suspensions of antibiotics: measuring procedures and administration devices. Pharmaceutics. 2021;13(4):528.

Rouaz K, Chiclana-Rodríguez B, Nardi-Ricart A, Suñé-Pou M, Mercadé-Frutos D, Suñé-Negre JM, et al. Excipients in the pediatric population: a review. Pharmaceutics. 2021;13(3):387.

Pérez RP, Garcia BS, Marrodán BR, Baquero-Artigao F, Fernándex-Llamazares CM, López-Ramos MG, et al. Recommendations for the preparation and administration of antituberculosis drugs in children. Second phase of the Magistral Project of the Spanish Network for the Study of Pediatric Tuberculosis [pTBred]. anales de pediatria. 2016;85(6):323.e1–323.e11.

Feja K, McCabe D, McSherry GD, Tortoriello S. Management of latent tuberculosis infection in children and adolescents. A guide for the primary care provider. New Jersey Medical School. 2009; Available from: https://globaltb.njms.rutgers.edu/downloads/products/PediatricGuidelines.pdf

Uchida S, Hiraoka S, Namiki N. Development of gummi drugs of aripiprazole as hospital formulations. Chem Pharm Bull. 2015;63(5):354–60.

Article  CAS  Google Scholar 

Lopez FL, Ernest TB, Tuleu C, Gul MO. Formulation approaches to pediatric oral drug delivery: benefits and limitations of current platforms. Expert Opin Drug Deliv. 2015;12(11):1727–40.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barnett S, Bhatt A. A chewable pediatric preparation of ibuprofen is palatable and acceptable to children. Paediatr Neonatal Pain. 2020;2(1):2–6.

Article  PubMed  PubMed Central  Google Scholar 

Tagami T, Ito E, Kida R, Hirose K, Noda T, Ozeki T. 3D printing of gummy drug formulations composed of gelatin and an HPMC-based hydrogel for pediatric use. Indian J Pharm. 2021;1:594.

Google Scholar 

Yoo O, Tang EKY, Salman S, Nguyen MN, Sommerfield D, Sommerfield A, et al. A randomised controlled trial of a novel tramadol chewable tablet: pharmacokinetics and tolerability in children. 2022;77(4):438–48.

CAS  Google Scholar 

Synaridou MS, Monou PK, Zacharis CK, Fatouros D, Panderi I, Markopoulou CK. Amoxicillin chewable tablets intended for pediatric use: formulation development, stability evaluation and taste assessment. Pharm Dev Technol. 2021;26(9):978–88.

Article  CAS  PubMed  Google Scholar 

Michele TM, Knorr B, Vadas EB, Reiss TF. Safety of chewable tablets for children. J Asthma. 2002;39(5):391–403.

Article  PubMed  Google Scholar 

Dillie MJ, Hattrem MN, Draget KI. Soft, chewable gelatin-based pharmaceutical oral formulations: a technical approach. Pharm Dev Technol. 2018;23(5):404–511.

Google Scholar 

Yousif TI, Bizanti K, Elnazir B. Uses of personalized medicine in current pediatrics. Int J Clin Pediatr. 2016;5(1):1–5.

Article  Google Scholar 

Scarpa M, Ceci A, Tomanin R, Mincarone P, Begley D. Personalised medicine in pediatrics: individualising treatment in children with rare neurological diseases. EPMA J. 2011;2:231–9.

Article  PubMed  PubMed Central  Google Scholar 

Zhu C, Tian Y, Zhang E, Gao X, Zhang H, Liu N, et al. Semisolid extrusion 3D printing of propranolol hydrochloride gummy chewable tablets: an innovative approach to prepare personalized medicine for pediatrics. AAPS PharmSciTech. 2022;233(166).

Herrada-Manchón H, Rodríguez-González D, Fernández AM, Suñé-Pou M, Pérez-Lozano P, García-Montoya E, et al. 3D printed gummies: personalized drug dosage in a safe and appealing way. Indian J Pharm. 2020;25:587.

Google Scholar 

Galande AD, Khurana NA, Mutalik S. Pediatric dosage forms—challenges and recent developments: A critical review. JAPS. 2020;10(7).

Matawo N, Adeleke OA, Wesley-Smith J. Optimal design, characterization and preliminary safety evaluation of an edible orodispersible formulation for pediatric tuberculosis pharmacotherapy. Int J Mol Sci. 2020;21(16):5714.

Jana A, Maity C, Halder SK, Mondal KC, Pati BR, Mohaptra PKD. Tannase Production by Penicillium purpurogenum PAF6 in solid state fermentation of tannin-rich plant residues following OVAT and RSM. Appl Biochem Biotechnol. 2012;22(167):1254–69.

Article  Google Scholar 

Baliga S, Muglikar S, Kale R. Salivary pH: a diagnostic biomarker. J Indian Soc Periodontol. 2013;17(4):461–5.

Article  PubMed  PubMed Central  Google Scholar 

Dixit MA, Sen PS, Raut RG. Soft-chew tablet pharmaceutical formulations. 17/893,265. 2022.

Cocirla E. Textural analysis test parameters. 2020. Available from: http://www.can-am.net

The United States Pharmacopeia Chapter 1092. 2004. The dissolution procedure: development and validation. Available from: https://latam-edu.usp.org/wp-content/uploads/2021/08/1092.pdf

Hamed R, Awadallah A, Sunoqrot S, Tarawneh O, Nazzal S, Albaraghthi T, et al. pH- dependent solubility and dissolution behavior of carvedilol–case example of a weakly basic BCS class II drug. AAPS PharmSciTech. 2016;17(2):418–26.

Article  CAS  PubMed  Google Scholar 

Amelian A, Wasilewska K, Wesoly M, Ciosek-Skibińska P, Winnicka K. Taste-masking assessment of orally disintegrating tablets and lyophilisates with cetirizine dihydrochloride microparticles. Saudi Pharm J. 2017;25(8):1144–50.

Article  PubMed  PubMed Central  Google Scholar 

Wang Z, Li J, Hong X, Han X, Liu B, Li X, et al. Taste masking study based on an electronic tongue: the formulation design of 3D printed levetiracetam instant-dissolving tablets. Pharm Res. 2021;38(5):831–42.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cole LA, Kramer PR. Human physiology, biochemistry and basic medicine. 1st ed. 2015.

Podraźka M, Bączyńska E, Kundys M, Jeleń PS, Nery EW. Electronic tongue—a tool for all tastes? Biosensors [Basel]. 2018;8(1):3.

Carazo E, Borrego-Sánchez A, García-Villén F, Sánchez-Espejo R, Aguzzi C, Viseras C, et al. Assessment of halloysite nanotubes as vehicles of isoniazid. Colloids Surf B. 2017;160:337–44.

Article  CAS  Google Scholar 

Coates J. Interpretation of infrared spectra, a practical approach. In Encyclopedia of analytical chemistry; Meyers, R. A., Ed: John Wiley & Sons Ltd: Chichester; 2006. 10815–10837 p.

Wojcik-Pastuszka D, Krzak J, Macikowski B, Berkowski R, Osiński B, Musial W. Evaluation of the release kinetics of a pharmacologically active substance from model intra-articular implants replacing the cruciate ligaments of the knee. Materials. 2019;12(8):1202.

Zhu W, Long J, Shi M. Release kinetics model fitting of drugs with different structures from viscose fabric. Materials. 2023;16(8):3282.

Dash S, Murthy PN, Nath L, Chowdhury P. Kinetic modeling on drug release from controlled drug delivery systems. Acta Pol Pharm. 2010;67(3):217–23.

CAS  PubMed  Google Scholar 

Talevi A, Ruiz ME. Drug release. In: The ADME encyclopedia [Internet]. Springer, Cham.; 2021. Available from: https://doi.org/10.1007/978-3-030-51519-5_32-1